Seeing Is Believing
Healthcare - Sector
with an average price target of $8.34. This is a potential upside of $8.34 (0%) from yesterday's end of day stock price of $0.
Acceleron Pharma's activity chart (see below) currently has 192 price targets and 123 ratings on display.
Analysts average stock forecasts to be materialized ratio is 85.92% with an average time for these price targets to be met of 197.45 days.
Most recent stock forecast was given by AKASH TEWARI from JEFFERIES on 06-Oct-2021. First documented stock forecast 14-Aug-2014.
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
Since 06-Oct-2021
$180
$1.25 (0.70%)
4 years 3 months 2 days ago
(06-Oct-2021)
0/2 (0%)
$4.71 (2.69%)
Hold
Since 30-Sep-2021
$180
4 years 3 months 3 days ago
(05-Oct-2021)
16/17 (94.12%)
$7.9 (4.59%)
257
Hold
Since 01-Oct-2021
$180
$1.25 (0.70%)
$173
4 years 3 months 7 days ago
(01-Oct-2021)
6/7 (85.71%)
$5.65 (3.24%)
201
Buy
Since 10-Jul-2018
$150
$-28.75 (-16.08%)
$150
4 years 3 months 7 days ago
(01-Oct-2021)
8/9 (88.89%)
$-24.35 (-13.97%)
284
Hold
Since 23-Mar-2021
$180
$1.25 (0.70%)
$148
4 years 3 months 7 days ago
(01-Oct-2021)
7/8 (87.5%)
$5.65 (3.24%)
289
What is XLRN (Acceleron Pharma) average time for price targets to be met?
Which analyst has the current highest performing score on XLRN (Acceleron Pharma) with a proven track record?
Which analyst has the most public recommendations on XLRN (Acceleron Pharma)?
Which analyst is the currently most bullish on XLRN (Acceleron Pharma)?
Which analyst is the currently most reserved on XLRN (Acceleron Pharma)?